<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39425109</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2431</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>18</Day></PubDate></JournalIssue><Title>BMC pediatrics</Title><ISOAbbreviation>BMC Pediatr</ISOAbbreviation></Journal><ArticleTitle>The impact of the COVID-19 pandemic on pediatric bloodstream infections and alteration in antimicrobial resistance phenotypes in Gram-positive bacteria, 2020-2022.</ArticleTitle><Pagination><StartPage>671</StartPage><MedlinePgn>671</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">671</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12887-024-05146-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Alteration in the etiology of pediatric bloodstream infections (BSIs) and antimicrobial resistance (AMR) is not well known during the Coronavirus disease 2019 (COVID-19) pandemic. This study aimed to investigate the impact of the COVID-19 pandemic on pediatric BSIs and alteration in antimicrobial resistance phenotypes in Gram-positive bacteria.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The frequency of BSIs among children under 18 years old was retrospectively recorded in a tertiary children's hospital in Tehran, Iran from February 2020 to December 2022. The status of COVID-19 infection using reverse transcription polymerase chain reaction, bacteremia/fungemia according to BACTEC 9120 Culture System results, characterization of bacteria using biochemical tests, and antimicrobial susceptibility patterns for Gram-positive bacterial isolates using disk diffusion method were determined. Statistical analysis was done to measure the correlation of COVID-19 infection with BSIs and AMR.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Out of 13,345 COVID-19 tests and 4,194 BACTEC blood culture requests, bacteremia/fungemia were confirmed in 10.37% (435/4,194) of the patients who requested both tests simultaneously. The COVID-19 infection was confirmed in 25.3% (110/435) of the patients with bacteremia/fungemia. The infection with characterized Gram-positive bacteria (GPB) and fungi was detected in 32.3% (140/433) and 8.31% (36/433) of the cases, respectively. Coagulase-negative Staphylococcus (CNS, 72, 16.62%), S. aureus (36, 8.3%), and Enterococcus spp. (22, 5%) were among the common isolates. Candida spp. and non-Candida yeasts were detected in 6.7% and 13.4% of the cases, respectively. A positive correlation was shown between the CNS bacteremia and COVID-19 infection (p-value = 0.019). Antibiotic susceptibility testing results showed the highest frequency of resistance to azithromycin among CNS, azithromycin and tetracycline among S. aureus and tetracycline among Enterococcus spp. Methicillin-resistance phenotype in the S. aureus (MRSA) and coagulase-negative Staphylococcus spp. (MR-CNS) was detected in 40% and 61.5% of the strains, respectively and the Enterococci were resistant to vancomycin in 33.3% of the isolates.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A decline in the trend of BSIs by GPB and an increase in AMR was shown in children during the COVID-19 pandemic. Increasing antibiotic resistance is a concern; however, chloramphenicol, linezolid, and vancomycin remain active against common causes of GPB-BSIs.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fallah</LastName><ForeName>Fatemeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karimi</LastName><ForeName>Abdollah</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pediatric Infections Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azimi</LastName><ForeName>Leila</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Pediatric Infections Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghandchi</LastName><ForeName>Ghazale</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Pediatric Infections Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gholinejad</LastName><ForeName>Zari</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Pediatric Infections Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdollahi</LastName><ForeName>Nafiseh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Pediatric Infections Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oskooie</LastName><ForeName>Nazanin Ahari</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Pediatric Infections Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khodaei</LastName><ForeName>Hannan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Pediatric Infections Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Armin</LastName><ForeName>Shahnaz</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pediatric Infections Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behzad</LastName><ForeName>Azita</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pediatric Intensive Care Department, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hashemi</LastName><ForeName>Seyedeh Masumeh</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Pediatric Intensive Care Department, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmadizadeh</LastName><ForeName>Seyedeh Narjes</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Pediatric Intensive Care Department, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alebouyeh</LastName><ForeName>Masoud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pediatric Infections Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran. masoud.alebouyeh@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>IR.SBMU.MSP.REC.1401.060</GrantID><Agency>Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Agency><Country /></Grant><Grant><GrantID>IR.SBMU.MSP.REC.1401.060</GrantID><Agency>Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Agency><Country /></Grant><Grant><GrantID>IR.SBMU.MSP.REC.1401.060</GrantID><Agency>Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Agency><Country /></Grant><Grant><GrantID>IR.SBMU.MSP.REC.1401.060</GrantID><Agency>Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Agency><Country /></Grant><Grant><GrantID>IR.SBMU.MSP.REC.1401.060</GrantID><Agency>Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Agency><Country /></Grant><Grant><GrantID>IR.SBMU.MSP.REC.1401.060</GrantID><Agency>Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Agency><Country /></Grant><Grant><GrantID>IR.SBMU.MSP.REC.1401.060</GrantID><Agency>Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Agency><Country /></Grant><Grant><GrantID>IR.SBMU.MSP.REC.1401.060</GrantID><Agency>Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Agency><Country /></Grant><Grant><GrantID>IR.SBMU.MSP.REC.1401.060</GrantID><Agency>Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Agency><Country /></Grant><Grant><GrantID>IR.SBMU.MSP.REC.1401.060</GrantID><Agency>Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Agency><Country /></Grant><Grant><GrantID>IR.SBMU.MSP.REC.1401.060</GrantID><Agency>Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Agency><Country /></Grant><Grant><GrantID>IR.SBMU.MSP.REC.1401.060</GrantID><Agency>Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Agency><Country /></Grant><Grant><GrantID>IR.SBMU.MSP.REC.1401.060</GrantID><Agency>Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Pediatr</MedlineTA><NlmUniqueID>100967804</NlmUniqueID><ISSNLinking>1471-2431</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016470" MajorTopicYN="Y">Bacteremia</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007492" MajorTopicYN="N" Type="Geographic">Iran</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016908" MajorTopicYN="Y">Gram-Positive Bacterial Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="Y">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024881" MajorTopicYN="N">Drug Resistance, Bacterial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006094" MajorTopicYN="N">Gram-Positive Bacteria</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016469" MajorTopicYN="N">Fungemia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bloodstream infections</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Child, hospitalized</Keyword><Keyword MajorTopicYN="N">Gram-positive bacteria</Keyword><Keyword MajorTopicYN="N">Microbial Sensitivity Test</Keyword><Keyword MajorTopicYN="N">Yeasts</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>19</Day><Hour>16</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>19</Day><Hour>16</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>23</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39425109</ArticleId><ArticleId IdType="pmc">PMC11487802</ArticleId><ArticleId IdType="doi">10.1186/s12887-024-05146-7</ArticleId><ArticleId IdType="pii">10.1186/s12887-024-05146-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Reinhart K, Kissoon N. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respiratory Med. 2018;6(3):223–30.</Citation><ArticleIdList><ArticleId IdType="pubmed">29508706</ArticleId></ArticleIdList></Reference><Reference><Citation>Laupland KB. Incidence of bloodstream infection: a review of population-based studies. Clin Microbiol Infect. 2013;19(6):492–500.</Citation><ArticleIdList><ArticleId IdType="pubmed">23398633</ArticleId></ArticleIdList></Reference><Reference><Citation>Sajedi Moghaddam S, Mamishi S, Pourakbari B, Mahmoudi S. Bacterial etiology and antimicrobial resistance pattern of pediatric bloodstream infections: a 5-year experience in an Iranian referral hospital. BMC Infect Dis. 2024;24(1):373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10988941</ArticleId><ArticleId IdType="pubmed">38565980</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaller MA, Andes DR, Diekema DJ, Horn DL, Reboli AC, Rotstein C, Franks B, Azie NE. Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the prospective antifungal therapy (PATH) registry 2004–2008. PLoS ONE. 2014;9(7): e101510.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4081561</ArticleId><ArticleId IdType="pubmed">24991967</ArticleId></ArticleIdList></Reference><Reference><Citation>Barantsevich N, Barantsevich E. Diagnosis and Treatment of Invasive Candidiasis. Antibiotics (Basel). 2022;11(6):718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9219674</ArticleId><ArticleId IdType="pubmed">35740125</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee WJ, Hsu JF, Chen YN, Wang SH, Chu SM, Huang HR, Yang PH, Fu RH, Tsai MH. Pediatric Candida Bloodstream Infections Complicated with mixed and subsequent bacteremia: the clinical characteristics and impacts on outcomes. J Fungi. 2022;8(11):1155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9695890</ArticleId><ArticleId IdType="pubmed">36354922</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, Colomb-Cotinat M, Kretzschmar ME, Devleesschauwer B, Cecchini M, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6300481</ArticleId><ArticleId IdType="pubmed">30409683</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiusaroli L, Liberati C, Rulli L, Barbieri E, De Pieri M, Di Chiara C, Mengato D, Giaquinto C, Donà D. Therapeutic options and outcomes for the treatment of children with gram-positive Bacteria with resistances of concern: a systematic review. Antibiotics (Basel). 2023;12(2):261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9952189</ArticleId><ArticleId IdType="pubmed">36830174</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S, Chauhan A, Ranjan A, Mathkor DM, Haque S, Ramniwas S, Tuli HS, Jindal T, Yadav V. Emerging challenges in antimicrobial resistance: implications for pathogenic microorganisms, novel antibiotics, and their impact on sustainability. Front Microbiol. 2024;15: 1403168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11089201</ArticleId><ArticleId IdType="pubmed">38741745</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik SS, Mundra S. Increasing consumption of antibiotics during the COVID-19 pandemic: implications for Patient Health and Emerging Anti-microbial Resistance. Antibiot (Basel Switzerland). 2022;12(1):45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9855050</ArticleId><ArticleId IdType="pubmed">36671246</ArticleId></ArticleIdList></Reference><Reference><Citation>Tehrani N, Azimi L, Jabbari S, Bayekolaei R, Azimi T, Ghandchi G, Maham S, Fallah F. Bacteremia with multi-drug resistant gram-negative bacteria in pediatrics and its correlation with COVID-19. Arch Clin Infect Dis. 2023;18(4):e136159.</Citation></Reference><Reference><Citation>Wormser G. Manual of Clinical Microbiology vol. 46, 9 edn. Washington, DC: ASM; 2008.</Citation></Reference><Reference><Citation>Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 32nd ed. CLSI supplement M100 (ISBN 978-1-68440-134-5 [Print]; ISBN978-1-68440-135-2 [Electronic]). Clinical and Laboratory Standards Institute. USA: 2022.</Citation></Reference><Reference><Citation>Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–81.</Citation><ArticleIdList><ArticleId IdType="pubmed">21793988</ArticleId></ArticleIdList></Reference><Reference><Citation>Alebouyeh M, Aavani P, Abdulrahman NA, Haleem AA, Karimi A, Armin S, Fallah F, Amirali A, Sadr S, Ghandchi G, et al. Re-positive PCR of SARS-CoV-2 in health care persons during COVID-19 pandemic. Cell Mol Biol. 2022;67(5):138–43.</Citation><ArticleIdList><ArticleId IdType="pubmed">35818260</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansour Ghanaie R, Boone I, Shamshiri AR, Karimi A, Amirali A, Marhamati N, Rostami MH, Pashaei N, Janbazi S, Azimi L, et al. Seroepidemiological and Molecular Survey for the detection of SARS-CoV-2 infection among children in Iran, September 2020 to June 2021: 1-Year cross-sectional study. Microorganisms. 2023;11(7):1672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10386463</ArticleId><ArticleId IdType="pubmed">37512845</ArticleId></ArticleIdList></Reference><Reference><Citation>Pana ZD, El-Shabrawi M, Sultan MA, Murray T, Alam A, Yewale V, Dharmapalan D, Klein JD, Haddad J, Thacker N, et al. Fighting the hidden pandemic of antimicrobial resistance in paediatrics: recommendations from the International Pediatric Association. BMJ Paediatrics open. 2023;7(1):e002084.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10387713</ArticleId><ArticleId IdType="pubmed">37500294</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon JH, Nickel KB, Reske KA, Stwalley D, Dubberke ER, Lyons PG, Michelson A, McMullen K, Sahrmann JM, Gandra S, et al. Risk factors for hospital-acquired infection during the SARS-CoV-2 pandemic. J Hosp Infect. 2023;133:8–14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9724556</ArticleId><ArticleId IdType="pubmed">36493966</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker MA, Sands KE, Huang SS, Kleinman K, Septimus EJ, Varma N, Blanchard J, Poland RE, Coady MH, Yokoe DS, et al. The impact of Coronavirus Disease 2019 (COVID-19) on Healthcare-Associated infections. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2022;74(10):1748–54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8385925</ArticleId><ArticleId IdType="pubmed">34370014</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturm LK, Saake K, Roberts PB, Masoudi FA, Fakih MG. Impact of COVID-19 pandemic on hospital onset bloodstream infections (HOBSI) at a large health system. Am J Infect Control. 2022;50(3):245–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8714610</ArticleId><ArticleId IdType="pubmed">34971717</ArticleId></ArticleIdList></Reference><Reference><Citation>Solís-Huerta F, Martinez-Guerra BA, Roman-Montes CM, Tamez-Torres KM, Rajme-Lopez S, Ortíz-Conchi N, López-García NI, Villalobos-Zapata GY, Rangel-Cordero A, Santiago-Cruz J, et al. Risk factors Associated with the development of hospital-acquired infections in hospitalized patients with severe COVID-19. Antibiotics. 2023;12(7): 1108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10376785</ArticleId><ArticleId IdType="pubmed">37508204</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceparano M, Sciurti A, Isonne C, Baccolini V, Migliara G, Marzuillo C, Natale F, Terrin G, Villari P, Group TC. Incidence of Healthcare-Associated Infections in a neonatal Intensive Care Unit before and during the COVID-19 pandemic: a four-year retrospective cohort study. J Clin Med. 2023;12(7):2621.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10094878</ArticleId><ArticleId IdType="pubmed">37048704</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloot R, Nsonwu O, Chudasama D, Rooney G, Pearson C, Choi H, Mason E, Springer A, Gerver S, Brown C, et al. Rising rates of hospital-onset Klebsiella spp. and Pseudomonas aeruginosa bacteraemia in NHS acute trusts in England: a review of national surveillance data, August 2020-February 2021. J Hosp Infect. 2022;119:175–81.</Citation><ArticleIdList><ArticleId IdType="pubmed">34547320</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G, Scaravilli V, Mangioni D, Scudeller L, Alagna L, Bartoletti M, Bellani G, Biagioni E, Bonfanti P, Bottino N, et al. Hospital-Acquired infections in critically ill patients with COVID-19. Chest. 2021;160(2):454–65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8056844</ArticleId><ArticleId IdType="pubmed">33857475</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H, Wu K, Chen H, Wang J, Chen L, Lai Z, Lin S. The impact of the COVID-19 pandemic on nosocomial infections: a retrospective analysis in a tertiary maternal and child healthcare hospital. Front. Public Health. 2023;11:1132323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10151874</ArticleId><ArticleId IdType="pubmed">37143971</ArticleId></ArticleIdList></Reference><Reference><Citation>Azimi T, Maham S, Fallah F, Azimi L, Gholinejad Z. Evaluating the antimicrobial resistance patterns among major bacterial pathogens isolated from clinical specimens taken from patients in Mofid Children’s Hospital, Tehran, Iran: 2013–2018. Infect drug Resist. 2019;12:2089–102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6645606</ArticleId><ArticleId IdType="pubmed">31410032</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Ma J, Guo P, Gao K, Yang J, Sun H. Changes of coagulase-negative Staphylococci infections in children before and after the COVID-19 pandemic in Zhengzhou, China. J Infect. 2023;86(2):154–225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9742061</ArticleId><ArticleId IdType="pubmed">36521565</ArticleId></ArticleIdList></Reference><Reference><Citation>Michels R, Last K, Becker SL, Papan C. Update on Coagulase-Negative Staphylococci-What the Clinician Should Know. Microorganisms. 2021;9(4):830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8070739</ArticleId><ArticleId IdType="pubmed">33919781</ArticleId></ArticleIdList></Reference><Reference><Citation>Diekema DJ, Hsueh PR, Mendes RE, Pfaller MA, Rolston KV, Sader HS, Jones RN. The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother. 2019;63(7):10–128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6591610</ArticleId><ArticleId IdType="pubmed">31010862</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray JW. A 7-year study of bloodstream infections in an English children’s hospital. Eur J Pediatrics. 2004;163(9):530–5.</Citation><ArticleIdList><ArticleId IdType="pubmed">15241687</ArticleId></ArticleIdList></Reference><Reference><Citation>Dramowski A, Cotton MF, Rabie H, Whitelaw A. Trends in paediatric bloodstream infections at a South African referral hospital. BMC Pediatr. 2015;15:33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4396163</ArticleId><ArticleId IdType="pubmed">25884449</ArticleId></ArticleIdList></Reference><Reference><Citation>Lisowska-Łysiak K, Lauterbach R, Międzobrodzki J, Kosecka-Strojek M. Epidemiology and Pathogenesis of Staphylococcus Bloodstream Infections in humans: a review. Pol J Microbiol. 2021;70(1):13–23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8330453</ArticleId><ArticleId IdType="pubmed">33815523</ArticleId></ArticleIdList></Reference><Reference><Citation>Zingg W, Hopkins S, Gayet-Ageron A, Holmes A, Sharland M, Suetens C. Health-care-associated infections in neonates, children, and adolescents: an analysis of paediatric data from the European centre for Disease Prevention and Control point-prevalence survey. Lancet Infect Dis. 2017;17(4):381–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">28089444</ArticleId></ArticleIdList></Reference><Reference><Citation>Alebouyeh M, Shirvani F, Hassanzadeh R, Azimi T, Ghandchi G, Abdollahi N, Gholinejad Z, Behzad A, Sheikhi Z, Fallah F, et al. Intestinal colonization of Vancomycin-resistant Enterococcus in children admitted to Mofid children’s hospital intensive care unit at admission and at discharge. Mol Biol Rep. 2023;50(4):3271–81.</Citation><ArticleIdList><ArticleId IdType="pubmed">36710317</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirvani F, Hassanzadeh R, Attaran B, Ghandchi G, Abdollahi N, Gholinejad Z, Sheikhi Z, Behzad A, Fallah F, Azimi L, et al. The intestinal carrier status of Enterococcus spp. in children: clonal diversity and alterations in resistance phenotypes before and after admission to a pediatric intensive care unit. BMC Pediatr. 2023;23(1):434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10466818</ArticleId><ArticleId IdType="pubmed">37648974</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlgren D, Lennernäs H. Review on the effect of chemotherapy on the intestinal barrier: epithelial permeability, mucus and bacterial translocation. Biomed Pharmacother. 2023;162:114644.</Citation><ArticleIdList><ArticleId IdType="pubmed">37018992</ArticleId></ArticleIdList></Reference><Reference><Citation>Tural Kara T, Erat T, Yahşi A, Özdemir H, İleri T, İnce E, Taçyıldız N, Ünal E, Çiftçi E, İnce E. Bloodstream infections in pediatric hematology/oncology patients: six years’ experience of a single center in Turkey. Turk J Med Sci. 2019;49(4):1157–64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7018311</ArticleId><ArticleId IdType="pubmed">31342734</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas L, Muñoz P, Kestler M, Arroyo D, Guembe M, Rodríguez-Créixems M, Verde E, Bouza E. Bloodstream infections in patients with kidney disease: risk factors for poor outcome and mortality. J Hosp Infect. 2013;85(3):196–205.</Citation><ArticleIdList><ArticleId IdType="pubmed">24001997</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe N, Otsuka Y, Watari T, Hosokawa N, Yamagata K, Fujioka M. Time to positivity of Corynebacterium in blood culture: characteristics and diagnostic performance. PLoS ONE. 2022;17(12): e0278595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9747040</ArticleId><ArticleId IdType="pubmed">36512568</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolesnichenko SI, Lavrinenko AV, Akhmaltdinova LL. Bloodstream Infection Etiology among Children and Adults. Int J Microbiol. 2021;2021:6657134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7939735</ArticleId><ArticleId IdType="pubmed">33727928</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarrafzadeh F, Sohrevardi SM, Abousaidi H, Mirzaei H. Prevalence of methicillin-resistant Staphylococcus aureus in Iranian children: a systematic review and meta-analysis. Clin Experimental Pediatr. 2021;64(8):415–21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8342872</ArticleId><ArticleId IdType="pubmed">33227182</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelaziz Abdelmoneim S, Mohamed Ghazy R, Anwar Sultan E, Hassaan MA, Anwar Mahgoub M. Antimicrobial resistance burden pre and post-COVID-19 pandemic with mapping the multidrug resistance in Egypt: a comparative cross-sectional study. Sci Rep. 2024;14(1):7176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10966009</ArticleId><ArticleId IdType="pubmed">38531847</ArticleId></ArticleIdList></Reference><Reference><Citation>Golli AL, Zlatian OM, Cara ML, Olteanu M. Pre- and post-COVID-19 antimicrobial resistance pattern of pathogens in an intensive care unit. Pharmaceuticals. 2024;17(4):407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11054378</ArticleId><ArticleId IdType="pubmed">38675369</ArticleId></ArticleIdList></Reference><Reference><Citation>Taleb MH, Elmanama AA, Taleb AH, Tawfick MM. Pre- and post-COVID-19 antimicrobial resistance profile of bacterial pathogens, a comparative study in a tertiary hospital. J Infect Developing Ctries. 2023;17(5):597–609.</Citation><ArticleIdList><ArticleId IdType="pubmed">37279421</ArticleId></ArticleIdList></Reference><Reference><Citation>Langford BJ, Soucy JR, Leung V, So M, Kwan ATH, Portnoff JS, Bertagnolio S, Raybardhan S, MacFadden DR, Daneman N. Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis. Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis. 2023;29(3):302–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9733301</ArticleId><ArticleId IdType="pubmed">36509377</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiner-Lastinger LM, Pattabiraman V, Konnor RY, Patel PR, Wong E, Xu SY, Smith B, Edwards JR, Dudeck MA. The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: a summary of data reported to the National Healthcare Safety Network. Infect Control Hosp Epidemiol. 2021;43(1):12–25.</Citation><ArticleIdList><ArticleId IdType="pubmed">34473013</ArticleId></ArticleIdList></Reference><Reference><Citation>Polemis M, Mandilara G, Pappa O, Argyropoulou A, Perivolioti E, Koudoumnakis N, Pournaras S, Vasilakopoulou A, Vourli S, Katsifa H et al: COVID-19 and Antimicrobial Resistance: Data from the Greek Electronic System for the Surveillance of Antimicrobial Resistance-WHONET-Greece (January 2018-March 2021). Life (Basel, Switzerland) 2021, 11(10):996.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8538738</ArticleId><ArticleId IdType="pubmed">34685368</ArticleId></ArticleIdList></Reference><Reference><Citation>Brissaud O, Guichoux J, Harambat J, Tandonnet O, Zaoutis T. Invasive fungal disease in PICU: epidemiology and risk factors. Ann Intensiv Care. 2012;2(1):6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3306204</ArticleId><ArticleId IdType="pubmed">22356683</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>